Answer
Feb 03, 2026 - 08:04 AM
Erlotinib is primarily used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by blocking the activity of a protein called epidermal growth factor receptor (EGFR), which helps cancer cells grow. Erlotinib is often used in patients whose cancer has specific EGFR mutations.
